Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axogen, Inc. - Common Stock (NQ:AXGN)

23.00 +0.78 (+3.51%)
Streaming Delayed Price Updated: 11:39 AM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Axogen, Inc. - Common Stock

< Previous 1 2 3 Next >
Keep an eye on the top gainers and losers in Wednesday's session.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga
Earnings Scheduled For October 29, 2025
 
Via Benzinga
Why Is Axogen Stock Down 11% In Pre-Market Today?
Via Stocktwits
Earnings Scheduled For August 5, 2025
 
Via Benzinga
Earnings Scheduled For May 8, 2025
 
Via Benzinga
Analyst Expectations For Axogen's Future
 
Via Benzinga
Axogen Inc (NASDAQ:AXGN) Surges on Strong Q3 2025 Earnings Beat and Raised Guidance
Axogen (AXGN) stock surged after Q3 2025 earnings beat estimates. Revenue grew 23.5% to $60.1M, while adjusted EPS of $0.12 crushed forecasts. The company also raised its full-year guidance. 
Via Chartmill
Topics Earnings
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday
 
Via Benzinga
FDA Pushes Back Axogen Avance Nerve Graft Decision By 3 Months
FDA delays Axogen's Avance Nerve Graft BLA review to December 5, after new data submission, while the company raises its full-year revenue outlook. 
Via Benzinga
Earnings Scheduled For February 25, 2025
 
Via Benzinga
Why Axogen Stock, Up 76% Over The Last Two Months, Just Plummeted
The FDA's move is largely procedural, says one analyst, but it adds incremental uncertainty. 
Via Investor's Business Daily
Which stocks are moving before the opening bell on Monday?
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Axogen (AXGN) Q2 Revenue Jumps 18%
Via The Motley Fool
Axogen Inc (NASDAQ:AXGN) Surges 15.8% After Q2 2025 Earnings Beat and Raised Guidance
Axogen Inc (AXGN) surpasses Q2 2025 estimates with strong revenue and EPS growth, raises full-year guidance, sparking a 15.8% pre-market stock surge. 
Via Chartmill
Topics Earnings
These stocks are moving in today's pre-market session
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
These stocks are moving in today's after hours session
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
What Analysts Are Saying About Axogen Stock
 
Via Benzinga
Which stocks are gapping on Thursday?
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
Via Chartmill
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q2 2024
AXGN stock results show that Axogen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
AXGN Stock Earnings: Axogen Beats EPS, Misses Revenue for Q1 2024
AXGN stock results show that Axogen beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.